Close

Are you in compliance?

Don't miss out! Sign up today for our weekly newsletters and stay abreast of important GRC-related information and news.

Get updates on Compliance Week offerings, including new features, databases, research, and other resources, along with announcements of upcoming Webcasts, conferences, seminars, CPE/CLE opportunities and more.

Published every Thursday, Compliance Week Europe offers a condensed summary of risk, audit, and compliance news either originating in Europe, or of special interest to European compliance professionals. This newsletter will follow developments by the European Commission, as well as those of national governments across the region, or any U.S.-based news that might have consequence across the Atlantic. Frequency: weekly; Thursday a.m.

A fresh edition of Compliance Week delivered via e-mail and online every Tuesday morning, relentlessly focused on the disclosure, reporting and compliance requirements of our 25,000+ paying subscribers.

Published every Friday, Compliance Weekend was launched at the behest of subscribers, and offers a quick Plain English review of the week's key developments. We hope you enjoy this supplement to Compliance Week's Tuesday edition.

×

Status message

Start your free, no obligation 10-day trial to continue exploring with full access.

Navigating the FCPA Within the Medical Device Industry

Andrew Finkelstein | September 11, 2012

In the medical device industry, recent healthcare reforms such as the Federal Sunshine Act and the medical device tax present new and challenging regulatory risks.

In the absence of enforcement precedent, or even regulatory guidance, assessment and management of these risks have yet to yield a set of best practices. Of course, even within longstanding areas of regulatory compliance, and where there is ample precedent and guidance, there are still plenty of lessons to be learned, especially as regulators increasingly turn their eye to new areas of enforcement for the industry.

For example, the onslaught of Foreign Corrupt Practices Act enforcement actions in the medical device industry is evidence of the compliance challenges for the industry and the risks that face this increasingly global medical marketplace.

Why the crackdown on bribery... To get the full story, subscribe now.